Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza for Delayed Onset Muscle Soreness
NCT00805870Phase 2Completed
- Sponsor
- Western Michigan University
- Start
- Mar 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid in delayed onset muscle soreness (DOMS), sponsored by Western Michigan University. Started Mar 2009; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
delayed onset muscle soreness (DOMS)
Beyond the preview
Go deeper on NCT00805870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805870.